We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back to Event-Details

Novel Therapeutic Approaches

Track:
Medicines of the Future: What Will Innovation Need and Bring?

Day & Time:
April 18, 10:30AM - 12:00PM (Central Europe Standard Time)

Session Number:
S0301

Room Number:
Shanghai 1-2

Type:
Session

Title:
Novel Therapeutic Approaches

Chair(s):
Dolca Thomas
Vice President Translational Medicine for Immunology, Inflammation and Infectiou
F. Hoffmann-La Roche, Switzerland

Description:
Many novel therapeutic approaches are on the horizon which the promise to address the unmet needs of patients. However, some of these approaches will challenge current approaches to drug development, regulation and the health technology assessment. A multi-stakeholder round table.

Presentation(s) & Speaker(s):
Panel Discussion
Tomasz Lawniczek, DrMed
Senior Clinical Development Medical Director
Novartis, Switzerland

Panel Discussion
Sheuli Porkess, MD, MRCP, FFPM
Deputy Chief Scientific Officer
ABPI, United Kingdom

Panel Discussion
Corinne de Vries, PhD, MA, MSc, FISPE
Head of Science and Innovation Support (ad interim)
European Medicines Agency, United Kingdom

Panel Discussion
Niklas Hedberg, MPharm
Chief Pharmacist
Dental and Pharmaceutical Benefits Agency, TLV, Sweden